导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -15.31% | 919/1050 |
| 近一周 | -1.46% | 705/1104 |
| 近一月 | -2.32% | 159/1103 |
| 近一季 | 5.54% | 140/1094 |
| 近半年 | -12.80% | 865/1074 |
| 近一年 | -24.54% | 949/1020 |
| 近两年 | -4.02% | 900/926 |
| 近三年 | -27.73% | 802/834 |
| 成立以来 | 40.49% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-7.87% 947/1070 |
-13.63% 993/1101 |
- - |
- - |
| 2025 | -0.30% 934/1065 |
2.72% 577/1014 |
-0.23% 708/1038 |
5.20% 931/1050 |
-7.53% 820/1065 |
| 2024 | -10.83% 780/1011 |
-0.56% 344/960 |
-7.37% 761/983 |
8.93% 722/991 |
-11.14% 932/1011 |
| 2023 | -16.02% 565/952 |
1.31% 552/880 |
-9.31% 745/895 |
-6.48% 388/915 |
-2.26% 251/952 |
| 2022 | -29.01% 595/867 |
-23.98% 707/773 |
11.39% 209/806 |
-16.17% 625/845 |
0.01% 445/867 |
| 2021 | -1.79% 378/740 |
0.36% 139/580 |
7.80% 413/659 |
-15.92% 625/704 |
7.98% 128/740 |
| 2020 | 53.40% 223/554 |
13.65% 22/419 |
36.03% 59/466 |
3.72% 376/517 |
-4.34% 510/554 |
| 2019 | 71.43% 32/410 |
39.94% 64/1146 |
4.84% 46/1228 |
1.15% 301/390 |
15.52% 44/410 |
| 2018 | -17.33% 43/349 |
- - |
6.20% 14/990 |
-7.51% 624/1000 |
-12.72% 693/1080 |
| 2017 | 31.06% 34/285 |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票C | 0.8165 | 61.04% |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商医药健康产业股票 | 2.6450 | 53.78% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 嘉实医疗保健股票 | 2.6190 | 42.34% |
| 前海开源公共卫生股票C | 0.4647 | 42.24% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 广发医药精选股票C | 1.3103 | 40.86% |
| 交银医药创新股票C | 3.0948 | 37.26% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 中欧消费主题股票A VS. 东吴新产业精选股票A(580008) |